Acorah Software Products - Accounts Production 16.1.300 false true false true No description of principal activity 22 November 2023 30 November 2024 30 November 2024 15301509 Mrs Marie Chivers iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15301509 2023-11-21 15301509 2024-11-30 15301509 2023-11-22 2024-11-30 15301509 frs-core:CurrentFinancialInstruments 2024-11-30 15301509 frs-bus:PrivateLimitedCompanyLtd 2023-11-22 2024-11-30 15301509 frs-bus:FilletedAccounts 2023-11-22 2024-11-30 15301509 frs-bus:Micro-entities 2023-11-22 2024-11-30 15301509 frs-bus:AuditExempt-NoAccountantsReport 2023-11-22 2024-11-30 15301509 frs-bus:Director1 2023-11-22 2024-11-30
Registered number: 15301509
Facilipharma Ltd
Unaudited Financial Statements
For the Period 22 November 2023 to 30 November 2024
Nasa Consulting Ltd
5th Floor Blok
1 Castle Park
Bristol
BS2 0JA
Balance Sheet
Registered number: 15301509
30 November 2024
£
Fixed assets 1,434
Current assets 32,100
Creditors: Amounts Falling Due Within One Year (16,292 )
NET CURRENT ASSETS 15,808
TOTAL ASSETS LESS CURRENT LIABILITIES 17,242
NET ASSETS 17,242
CAPITAL AND RESERVES 17,242

Notes

1. General Information
Facilipharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15301509 . The registered office is 3 Clay Chimneys Albury Road, Furneux Pelham, Buntingford, SG9 0LP.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mrs Marie Chivers
Director
27/03/2025